Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs

Fibroblastic reticular cells influence the function of lymphocytes in secondary lymphoid organs. Ludewig and colleagues demonstrate that they also specifically restrain the activation of group 1 innate lymphoid cells in the presence of microbial stimulation to prevent immunopathology. Fibroblastic r...

Full description

Saved in:
Bibliographic Details
Published inNature immunology Vol. 17; no. 12; pp. 1388 - 1396
Main Authors Gil-Cruz, Cristina, Perez-Shibayama, Christian, Onder, Lucas, Chai, Qian, Cupovic, Jovana, Cheng, Hung-Wei, Novkovic, Mario, Lang, Philipp A, Geuking, Markus B, McCoy, Kathy D, Abe, Shinya, Cui, Guangwei, Ikuta, Koichi, Scandella, Elke, Ludewig, Burkhard
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.12.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fibroblastic reticular cells influence the function of lymphocytes in secondary lymphoid organs. Ludewig and colleagues demonstrate that they also specifically restrain the activation of group 1 innate lymphoid cells in the presence of microbial stimulation to prevent immunopathology. Fibroblastic reticular cells (FRCs) of secondary lymphoid organs form distinct niches for interaction with hematopoietic cells. We found here that production of the cytokine IL-15 by FRCs was essential for the maintenance of group 1 innate lymphoid cells (ILCs) in Peyer's patches and mesenteric lymph nodes. Moreover, FRC-specific ablation of the innate immunological sensing adaptor MyD88 unleashed IL-15 production by FRCs during infection with an enteropathogenic virus, which led to hyperactivation of group 1 ILCs and substantially altered the differentiation of helper T cells. Accelerated clearance of virus by group 1 ILCs precipitated severe intestinal inflammatory disease with commensal dysbiosis, loss of intestinal barrier function and diminished resistance to colonization. In sum, FRCs act as an 'on-demand' immunological 'rheostat' by restraining activation of group 1 ILCs and thereby preventing immunopathological damage in the intestine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1529-2908
1529-2916
DOI:10.1038/ni.3566